Last edition
News about Global Pharma
FDA Grants Approval to PPMD DUVYZAT for Duchenne Patients
Parent Project Muscular Dystrophy has been granted approval of DUVYZAT (givinostat) a histone deacetylase (HDAC) inhibitor indicated for individuals diagnosed with Duchenne six years of age and older by FDA.
Global Pharma | 22/03/2024 | By Manvi | 748
The acquisition is poised to enhance Lonza's large-scale biologics manufacturing capacity, catering to the growing demand for commercial mammalian contract manufacturing.
Global Pharma | 22/03/2024 | By Abha | 1301
Tonix Pharmaceuticals Secures Dual Manufacturing Partners for Potential Tonmya Launch
The biopharmaceutical company has selected two contract manufacturing organizations (CMOs), with one being Almac Pharma Services, a member of the Almac Group, as dual supply sources for Tonmya™.
Global Pharma | 22/03/2024 | By Abha | 1435
Samsung Accepts Healthcare Innovator Award for Contribution to Care in Underserved Communities
Boston Imaging was awarded HHM Health’s Healthcare Innovator Award for its SonoSync technology and contributions to closing the gap in quality, accessible healthcare for underserved communities.
Global Pharma | 21/03/2024 | By Manvi | 512
Babson Diagnostics to Launch Transformative Blood Testing Service with Leading Retail Partners
Babson Diagnostics announced that it will launch BetterWay™ blood testing with three retail partners in Austin and San Antonio.
Global Pharma | 21/03/2024 | By Manvi | 289
Phanes Therapeutics Earns FDA Fast Track Status for Pancreatic Adenocarcinoma Treatment
Phanes Therapeutics has announced that the US Food and Drug Administration has granted Fast Track designation to PT886 for the treatment of patients with metastatic claudin 18.2-positive pancreatic adenocarcinoma.
Global Pharma | 21/03/2024 | By Manvi | 1093
Roquette to Acquire IFF Pharma Solutions, Strengthening Position in Pharmaceutical Industry
The merger of Roquette and IFF Pharma Solutions will serve to rebalance Roquette's portfolio around the pillars of Health and Nutrition, expanding its pharma product range and accelerating its growth course.
Global Pharma | 21/03/2024 | By Abha | 617
Cognizant and NVIDIA Join Forces to Transform Drug Discovery with Gen AI Technology
The aim is to enhance productivity in the development process and accelerate the pace at which life-saving treatments can reach the market.
Global Pharma | 21/03/2024 | By Abha | 722
Corealis Pharma Lab Facilities to Be Fully Operational by 2024 End
Corealis Pharma Inc. has announced that the expansion project of its state-of-the-art laboratory facilities is completed ahead of schedule
Global Pharma | 21/03/2024 | By Manvi | 790
BerGenBio Begins Phase 2a in First Line NSCLC Patients with STK11m
BerGenBio ASA has initiated Phase 2a portion of the BGBC016 clinical study of its selective AXL inhibitor bemcentinib in combination with standard of care therapy in first-line Non-Small Cell Lung Cancer (NSCLC) patients
Global Pharma | 21/03/2024 | By Manvi | 696
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy